{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:38Z","timestamp":1790753858355,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008426","name":"Friedrich-Baur-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008434","name":"Mehr LEBEN f\u00fcr Krebskranke Kinder\u2014Bettina-Br\u00e4u-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Emerging technologies such as three-dimensional (3D) cell culture and the generation of biological matrices offer exciting new possibilities in disease modelling and tumour therapy. The paucity of laboratory models for hepatoblastoma (HB), the most prevalent malignant liver tumour in children, has hampered the identification of new treatment options for HB patients. We aimed to establish a reliable 3D testing platform using liver-derived scaffolds and HB cell lines that reflect the heterogeneous biology of the disease so as to allow reproducible preclinical research and drug testing.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In a sequence of physical, chemical and enzymatic decellularisation techniques mouse livers were stripped off all cellular components to obtain a 3D scaffold. HB cell lines were then seeded onto these scaffolds and cultivated for several weeks.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our newly generated biological scaffolds consist of liver-specific extracellular matrix components including collagen IV and fibronectin. A cultivation of HB cell lines on these scaffolds led to the formation of 3D tumour structures by infiltration into the matrix. Analyses of drug response to standard-of-care medication for HB showed reliable reproducibility of our stocked models.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Our HB models are easy-to-handle, producible at large scale, and can be cryopreserved for ready-to-use on-demand application. Our newly generated 3D HB platform may therefore represent a faithful preclinical model for testing treatment response in precision cancer medicine.<\/jats:p>","DOI":"10.3389\/fbioe.2023.1229490","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:31:05Z","timestamp":1700757065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Establishing a three-dimensional scaffold model of hepatoblastoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Elena Johanna","family":"Weigl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Hotes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Muensterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-4-431-68349-0_4","article-title":"Human hepatoma cell lines","volume-title":"Neoplasms of the liver","author":"Alexander","year":"1987"},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/bio.1170090604","article-title":"TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies","volume":"9","author":"Andreotti","year":"1994","journal-title":"J. Biolumin. Chemilumin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0971-9261.142001","article-title":"The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials","volume":"19","author":"Aronson","year":"2014","journal-title":"J. Indian Assoc. Pediatr. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12094-006-0177-7","article-title":"Mouse models in oncogenesis and cancer therapy","volume":"8","author":"C\u00e9spedes","year":"2006","journal-title":"Clin. Transl. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1016\/j.biomaterials.2011.01.057","article-title":"An overview of tissue and whole organ decellularization processes","volume":"32","author":"Crapo","year":"2011","journal-title":"Biomaterials"},{"key":"B6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.coph.2010.05.001","article-title":"Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue","volume":"10","author":"Cree","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/mop.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr. Opin. Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00204-011-0706-1","article-title":"Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool?","volume":"85","author":"De Kock","year":"2011","journal-title":"Arch. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/ijo.2010.860","article-title":"Development of a drug resistance model for hepatoblastoma","volume":"38","author":"Eicher","year":"2011","journal-title":"Int. J. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/01.cad.0000224445.23953.d9","article-title":"Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines","volume":"17","author":"Fernando","year":"2006","journal-title":"Anticancer Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5858\/2007-131-520-pfteos","article-title":"Protocol for the examination of specimens from pediatric patients with hepatoblastoma","volume":"131","author":"Finegold","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"204173142094290","DOI":"10.1177\/2041731420942903","article-title":"Decellularised scaffolds: just a framework? Current knowledge and future directions","volume":"11","author":"Garc\u00eda-Gareta","year":"2020","journal-title":"J. Tissue Eng."},{"key":"B13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.lungcan.2009.12.005","article-title":"Lung cancer cell lines: useless artifacts or invaluable tools for medical science?","volume":"68","author":"Gazdar","year":"2010","journal-title":"Lung Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1001\/jama.296.14.1731","article-title":"Translation of research evidence from animals to humans","volume":"296","author":"Hackam","year":"2006","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/bf02619623","article-title":"Establishment and characterization of a new human hepatocellular carcinoma cell line","volume":"20","author":"He","year":"1984","journal-title":"Vitro"},{"key":"B16","first-page":"37","article-title":"Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma","volume":"13","author":"Hirohashi","year":"1983","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The hope and the hype of organoid research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jpedsurg.2014.12.010","article-title":"Trends in incidence of childhood malignant solid tumors in Japan: estimation based on hospital-based registration","volume":"50","author":"Ikeda","year":"2015","journal-title":"J. Pediatr. Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/j.biomaterials.2014.01.024","article-title":"Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"B22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00103-012-1500-9","article-title":"The German cohort of long-term survivors of childhood cancer. A population-based cohort in the German Childhood Cancer Registry","volume":"55","author":"Kaatsch","year":"2012","journal-title":"Bundesgesundheitsblatt Gesundheitsforsch. Gesundheitsschutz"},{"key":"B23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1089\/ten.TEC.2012.0334","article-title":"Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue","volume":"19","author":"Kajbafzadeh","year":"2013","journal-title":"Tissue Eng. Part C Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1089\/ten.2004.10.1046","article-title":"Assessing porcine liver-derived biomatrix for hepatic tissue engineering","volume":"10","author":"Lin","year":"2004","journal-title":"Tissue Eng."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"L\u00f3pez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1200\/jco.2010.29.3837","article-title":"Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group","volume":"29","author":"Malogolowkin","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10555-007-9087-6","article-title":"On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing","volume":"26","author":"Man","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.1038\/srep13079","article-title":"Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation","volume":"5","author":"Mazza","year":"2015","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review","volume":"334","author":"Perel","year":"2007","journal-title":"Bmj"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B31","first-page":"809","article-title":"Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma","volume":"74","author":"Pietsch","year":"1996","journal-title":"Lab. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fped.2016.00022","article-title":"Hepatoblastoma: a need for cell lines and tissue banks to develop targeted drug therapies","volume":"4","author":"Rikhi","year":"2016","journal-title":"Front. Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/cancers12092668","article-title":"A human organoid model of aggressive hepatoblastoma for disease modeling and drug testing","volume":"12","author":"Saltsman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1089\/ten.TEA.2008.0587","article-title":"Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels","volume":"16","author":"Sellaro","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/ten.TEC.2010.0698","article-title":"A whole-organ regenerative medicine approach for liver replacement","volume":"17","author":"Soto-Gutierrez","year":"2011","journal-title":"Tissue Eng. Part C Methods"},{"key":"B36","first-page":"3032","article-title":"Increased risk of hepatoblastoma among immature children with a lower birth weight","volume":"58","author":"Tanimura","year":"1998","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/pbc.24213","article-title":"Genetics and epigenetics of hepatoblastoma","volume":"59","author":"Tomlinson","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1542\/peds.2015-0224","article-title":"Incidence, trends, and survival of children with embryonal tumors","volume":"136","author":"Tulla","year":"2015","journal-title":"Pediatrics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1096\/fasebj.5.13.1916105","article-title":"Collagen family of proteins","volume":"5","author":"Van Der Rest","year":"1991","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2007.08.006","article-title":"Modeling tissue morphogenesis and cancer in 3D","volume":"130","author":"Yamada","year":"2007","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.7150\/jca.52621","article-title":"LIN28A polymorphisms and hepatoblastoma susceptibility in Chinese children","volume":"12","author":"Yang","year":"2021","journal-title":"J. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.ejca.2012.06.023","article-title":"Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL)","volume":"48","author":"Zs\u00edros","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/s1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1200\/jco.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study","volume":"28","author":"Zs\u00edros","year":"2010","journal-title":"J. Clin. Oncol."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1229490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:31:09Z","timestamp":1700757069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1229490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":44,"alternative-id":["10.3389\/fbioe.2023.1229490"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2023.1229490","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1229490"}}